Management of high-risk colonoscopy patients.
Gastrointest. Endosc. Clin. N. Am., Oct;20(4):629-40 (2010)
The gastrointestinal complications of oncologic therapy.
Gastroenterol. Clin. North Am., Sep;39(3):629-47 (2010)
Barrett's Esophagus and esophageal adenocarcinoma.
Annu. Rev. Med., 60:221-31 (2009)
Gastrointestinal complications of oncologic therapy.
Nat Clin Pract Gastroenterol Hepatol., Dec;5(12):682-96 (2008)
Polyphenon E inhibits the growth of human Barrett's and aerodigestive adenocarcinoma cells by suppressing cyclin D1 expression.
Clin. Cancer Res., Jan;15(2):622-31 (2009)
Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity.
Cancer Res., Feb;69(4):1343-9 (2009)
Ability of integrated positron emission and computed tomography to detect significant colonic pathology: the experience of a tertiary cancer center.
Cancer., Mar;116(6):1454-61 (2010)
Galectin-3 modulates MUC2 mucin expression in human colon cancer cells at the level of transcription via AP-1 activation.
Gastroenterology., Nov;129(5):1581-91 (2005)
Phosphorylation of galectin-3 contributes to malignant transformation of human epithelial cells via modulation of unique sets of genes.
Cancer Res., Dec;65(23):10767-75 (2005)
Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy.
Cancer., Feb;106(3):552-8 (2006)
Impact of cyclin D1 A870G polymorphism in esophageal adenocarcinoma tumorigenesis.
Semin. Oncol., Dec;32(6 Suppl 9):S11-5 (2005)
Phosphorylated galectin-3 mediates tumor necrosis factor-related apoptosis-inducing ligand signaling by regulating phosphatase and tensin homologue deleted on chromosome 10 in human breast carcinoma cells.
J. Biol. Chem., Jul;282(29):21337-48 (2007)
COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett's oesophagus and oesophageal adenocarcinoma.
Gut., Nov;56(11):1512-21 (2007)
Chemoprevention of colorectal cancer: why all the confusion?
Curr. Opin. Gastroenterol., Jan;24(1):48-50 (2008)
Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer.
Cancer Res., Aug;68(15):6100-8 (2008)
Mucins and mucin binding proteins in colorectal cancer.
Cancer Metastasis Rev., 23(1-2):77-99 (2004)
Treatment of Hereditary Colorectal Cancer Syndromes.
Curr Treat Options Gastroenterol., Jun;7(3):213-224 (2004)
A circulating ligand for galectin-3 is a haptoglobin-related glycoprotein elevated in individuals with colon cancer.
Gastroenterology., Sep;127(3):741-8 (2004)
Clinical management of hereditary colorectal cancer syndromes.
Curr. Opin. Gastroenterol., Jan;20(1):32-42 (2004)
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.
N. Engl. J. Med., Mar;352(11):1092-102 (2005)